Pascal Joly

Principal • Catenion

Pascal Joly is an experienced principal at Catenion with specific expertise in cell and gene therapies. He has conducted multiple R&D portfolio and strategy assessments in Europe, US and Japan for early stage biotech and large biopharma companies. He holds a PhD in regenerative medicine from Charité – Berlin and spent two years as a postdoctoral fellow at Harvard University prior to joining Catenion in 2016. He lives in Luzern, Switzerland

Also speaking

Joel Eichmann

Co-Founder • Green Elephant Biotech

Alexandre Reeber

CEO • Core Biogenesis

Marcos Langtry

Director of Commercial Development, Allogeneic Cell Therapy • Lonza Ltd

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.